Feasibility of Using Bortezomib with or Without Chemotherapy in Patients with Atypical Teratoid/rhabdoid Tumors

计划入组 6 人 · 首次发布于 2025 年 2 月 28 日

Oxaliplatin in Treating Children With Recurrent or Refractory Medulloblastoma, Supratentorial Primitive Neuroectodermal Tumor, or Atypical Teratoid Rhabdoid Tumor

计划入组 43 人 · 首次发布于 2003 年 1 月 27 日

Combination Chemotherapy, Radiation Therapy, and an Autologous Peripheral Blood Stem Cell Transplant in Treating Young Patients With Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System

计划入组 70 人 · 首次发布于 2008 年 4 月 4 日

atypical antipsychotics (Lilly)

solid tumors therapy

DBI-500

BioLine Rx

Israel

Kura Oncology

United States

Crinetics

United States

LP-184 Receives FDA Rare Pediatric Disease Designations for Three Cancer Types

Paxalisib's Glioblastoma Pathway: FDA Suggests Standard Approval, Phase 3 Trial Alignment

Lantern Pharma's LP-184 Demonstrates Significant Survival Benefits in Pediatric Brain Cancer Models